Post on 04-Apr-2018
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
1/50
SclerodermaJoaquin masoud C. masoud, DMD,MScD
Part 1: introduc on, clinical feature,pathogenesis
University of the EASTPost Graduate School
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
2/50
scleroderma, (systemic sclerosis)
Autoimmune rheuma c diseases Its not contagious, it is not infec ous, it is not
cancerous or malignant.
Its a chronic disease Mul system disease of unknown e ology Pathogenesis include immune system ac va on ,
endothelial ac va on , and broblast ac va onthis results in small blood vessels damage andssue brosis.
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
3/50
Deni&on
1. Systemic sclerosis (scleroderma) - a mul system disorder characterized by
1) func onal and structural abnormali es of blood
vessels 2) brosis of the skin and internal organs 3) immune system ac va on
4) autoimmunity
2. Localized scleroderma - morphea, linear scleroderma
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
4/50
Epidemiology
It is Rare in children Its Peak is between age 35-65 More women affected then men Family history of other auto immune diseases Ethnic background inuence survival and
disease manifesta on.
( in iran, the prevalence is more betweencaspian people)
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
5/50
Environmental factors
1) infec on
2) occupa onal exposures: silica dust
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
6/50
Classica&on of systemic sclerosis
1. Diffuse cutaneous systemic sclerosis
1) proximal skin thickening
- distal and proximal extremity and often the trunk and
face
2) tendency to rapid progression of skin change
3) rapid onset of disease following Raynaudsphenomenon
4) early appearance of visceral involvement
5) poor prognosis
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
7/50
2. Limited cutaneous systemic sclerosis 1) symmetric restricted fibrosis - affecting the distal extremities and face/neck 2) prolonged delay in appearance of distinctive
internal manifestation 3) prominence of calcinosis and telangiectasia 4) good prognosis
* CREST syndrome - calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
8/50
Clinical features
Raynaud s Typical skin changes
Esophageal and small bowel dysfunction Interstitial lung disease Pulmonary hypertension
Renal crises
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
9/50
What is Raynaud s Phenomenon
Reversible skin color changes:White toblue to red
Due to vasospasm Induced by cold of emotion
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
10/50
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
11/50
Pallor phase cyano c phase
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
12/50
Causes of Raynaud s
Occlusive arterial disease Rheuma c
diseases:Scleroderma,CREST,MCTD,SLE,RA,Myosi s
Repe ve vascular injury
Hyperviscosity :Polycythemia,Cryoglobulinemia
Thoracic outlet syndrome
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
13/50
Clinical features
1. Vascular abnormali es 1) Raynaud's phenomenon - cold hands and feet
with reversible skin color change (white to blue to red) - induced by cold temperature or emo onal stress - ini al complaint in 3/4 of pa ents - 90% in pa ents with skin change
(prevalence in the general popula on: 4-15%) 2) digital ischemic injury
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
14/50
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
15/50
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
16/50
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
17/50
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
18/50
Esophageal dysmo lity:heart burn,andreux symptoms
Dilated esophagus on Esophagogram
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
19/50
Inters al Lung disease
Major cause of morbidly
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
20/50
Renal crises and hypertension inscleroderma
Major complic a on Early in disease rst few years Acute onset hypertension
High Renin Renal impairment Microangiopathic hemoly c anemia,Thrombocytopenia
Renal failure can be reversible if BP treated Drug of choice Angiotensin conver ng enzyme inhibitor
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
21/50
2.skin involvement:
1)
-edematous phase-indurative phase-atrophic phase2) firm,thickened bound tounderlying soft tissue3) Decrease in range of motion ,loss of facial expression, inabilityto open mouth fully
Clinical feature
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
22/50
Typical skin changes
Tight thick skin,peaked nose Pursed mouth
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
23/50
Salt and pepper pigmenta on
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
24/50
microstomia
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
25/50
Cold sensi vity
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
26/50
Edematous phase
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
27/50
Skin Indura on
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
28/50
Acrosclerosis
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
29/50
Skin microscopy
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
30/50
Terminal digit resorp on
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
31/50
Acrolysis
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
32/50
Digital pi ng scars
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
33/50
CREST syndrome: calcinosis cu s
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
34/50
Calcinosis and acrolysis
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
35/50
Telangiectasia
Face / mucous
membrane
blanched by pressure
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
36/50
Clinical features
4. intes nal involvement
1) esophagus: hypomo lity and retrosternal pain,
reux esophagi s, stricture
2) stomach: delayed emptying
3) small intes ne: pseudo-obstruc on, paraly c ileus,
malabsorp on4) large intes ne: chronic cons pa on and fecal
impac on diver cula
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
37/50
Abnormal mo lity
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
38/50
Diver cula
Barium enema study
- mul ple wide-mouthed
diver cula of colon
- broad base and neck
- usually asymptoma c
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
39/50
Diver cula
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
40/50
5. lungs 1) 2/3 of patients affected - leading cause of mortality and morbidity in later
stage of systemic sclerosis 2) pathology
- interstitial fibrosis - intimal thickening of pulmonary arterioles (pulmonary hypertension)
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
41/50
Pulmonary brosis
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
42/50
7.kidney 1) diffuse scleroderma in association with rapid progression of skin involvement
2) pathology - intimal hyperplasia of the interlobular artery - fibrinoid necrosis of afferent arterioles - glomerulosclerosis 3) proteinuria, abnormal sediment, azotemia, microangiopathic hemolytic anemia, renal failure
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
43/50
Kidney arteriogram
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
44/50
Kidney, In mal arterial brosis
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
45/50
Pathogenesis 1. Vasculopathy of small artery and capillary - endothelial cell injury - adhesion and activation of platelet - PDGF, thromboxane A2 release
- vasoconstriction & growth of endothelial cell and fibroblast - narrowing or obliteration, increased permeability 2. Fibrosis - aberrant regulation of fibroblast cell growth - increased production of extracellular matrix (collagen, fibronectin, and glycosaminoglycan) - thickening of the skin & fibrosis of internal organs
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
46/50
Pathogenesis
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
47/50
Pathogenesis 3. Immunologic mechanism 1) cell mediated immunity - skin: cellular infiltrates in perivascular region and
dermis (T cell, Langerhans cell, plasma cell,
macrophage)
2) humoral immunity - hypergammaglobulinemia - autoantibody production antinuclear antibody (+) > 95%
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
48/50
Pathogenesis
4. Environmental factors1) silica dust2) organic solvents3) biogenic amines
4) urea formaldehyde5) polyvinyl chloride6) rapeseed oil7) bleomycin8) L-tryptophan9) silicone implant
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
49/50
Part 2- to be discussed by Dr. Muzamil wani
7/31/2019 Sleroderma pdf-Dr. Jm Shafiee
50/50
Thank you